Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-24

FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for haloperidol decanoate by Sagent Pharmaceuticals, updating regulatory approval for this long-acting antipsychotic und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)